Haermonics

Haermonics aims to deliver an economical alternative for postoperative drainage products in the cardiac surgery market. On top of the economic value Haermonics delivers a cost-effective high-end technology product (drainage and flushing system) that is capable of providing smart clinical decision support by controlling and analysing surgical blood loss. Haermonics technology provides an integrated solution for surgical blood loss and wound healing, targeted versatile therapy, and smart integration within its complex working environment. The safety and ease that the Haermonics drainage technology has to offer will enable improved patient outcome after surgical procedures when compared to current standards

Clinical trials,medical devices,health tech innovations,open heart surgery,cardiac surgery,and perioperative management

Haermonics operates in the Medical equipment manufacturing industry.

Haermonics's revenue is 11m - 100m

Haermonics has 11 - 50 employees.